The Chemical Nature of Heart Failure

Article1 February 1939THE CHEMICAL NATURE OF HEART FAILUREGEORGE HERRMANN, M.D., F.A.C.P., GEORGE M. DECHERD JR., M.D., F.A.C.P.GEORGE HERRMANN, M.D., F.A.C.P., GEORGE M. DECHERD JR., M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-12-8-1233 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptHeart failure in its commonest and simplest form represents an inadequacy in contraction of a critical number of individual heart muscle cells. Every clinician has witnessed the death of patients with evidences of complete myocardial insufficiency only to have pathologists offer nothing more than slight microscopic myocardial changes to account for the clinical picture. In such instances, we have hesitated to admit the histological abnormalities as full explanation of the complete insufficiency in myocardial function. On the other hand we have seen serious and extensive pathological processes demonstrated in the hearts of patients who during life have shown no evidence...References1. MEAKINS JC: Muscle physiology and circulatory failure, ANN. INT. MED., 1932, vi, 506. LinkGoogle Scholar2. FISKESUBBAROW CHY: Phosphocreatine, Jr. Biol. Chem., 1929, lxxxi, 629. CrossrefGoogle Scholar3. EGGLETONEGGLETON PMG: Physiological significance of "Phosphagen," Jr. Physiol., 1927, lxiii, 155. CrossrefGoogle Scholar4. HARRISON TR: : The failure of the circulation, 1935, Williams and Wilkins, Baltimore. CrossrefGoogle Scholar5. EVANSDE GRAFFKOSAKAMACKENZIEMURPHYVACEKWILLIAMSYOUNG CLACTKGETDHFG: Utilization of blood sugar and lactate by heartlung preparation, Jr. Physiol., 1933, lxxx, 21. CrossrefGoogle Scholar6. CRUICKSHANK EW: Cardiac metabolism, Physiol. Rev., 1936, xvi, 597. CrossrefGoogle Scholar7. HIMWICHGOLDFARBNAHUSA HEAH: Changes in the carbohydrate metabolism of the heart following coronary occlusion, Am. Jr. Physiol., 1934, cix, 403. CrossrefGoogle Scholar8. EPPINGERLASZOLSCHUERMYER HDA: Ueber die mutmasslichen Ursachen der Unökonomie in Herzfehlerorganismus, Klin. Wchnschr., 1928, vii, 2231. CrossrefGoogle Scholar9. JAHN D: (a) Der Einfluss experimenteller Mitralinsuffizienz auf den Stoffwechsel, Arch. f. exper. Path. u. Pharm., 1935, clxxiii, 221; (b) Stoffwechsel and Kreislauf bei der Dekompensation des Herzens, Klin. Wchnschr., 1935, xiv, 1061. Google Scholar10. LUNDSGAARD E: Untersuchungen üeber Muskelkontraktion ohne Milchsäurebildung, Biochem. Ztschr., 1930, ccxvii, 162. Google Scholar11. EMBDEN G: Chemismus der Muskelkontraktion und Chemie der Muskelkontraktur, Handb. d. norm. u. path. Physiol., 1925, viii, 369. Google Scholar12. LEHNARTZ E: Die chemischen Vorgänge bei der Muskelkontraktion, Ergebn. d. Physiol., 1933, xxxv, 874. CrossrefGoogle Scholar13. EMBDENDEUTICKE GHJ: Ueber die Bedeutung der Phosphoglycerinsäure für die Glykolyse in der Muskulatur, Ztschr. f. physiol. Chem., 1934, ccxxx, 50. CrossrefGoogle Scholar14. LOHMANMEYERHOF KO: Ueber die enzymatische Umwandlung von Phosphoglycerinsäure in Brenztraubensäure und Phosphorsäure, Biochem. Ztschr., 1934, cclxxiii, 60. Google Scholar15. MEYERHOF O: Die chemischen Vorgänge in Muskel, 1930, Julius Springer, Berlin. Google Scholar16. CLARKEGGLETONEGGLETON AJMGP: Phosphagen in the perfused heart of the frog, Jr. Physiol., 1932, lxxv, 332. CrossrefGoogle Scholar17. VOLLMER HZ: Untersuchungen ueber den Kreatin- und Phosphorsäure-gehalt verschiedener Herzteile, Ztschr. ges. exp. Med., 1929, lxv, 522. CrossrefGoogle Scholar18. POHLE K: Ueber das Vorkommen von Muskeladenylsäure und Hexose monophosphorsäure (Lactacidogen) in Herzen, Ztschr. f. physiol. Chem., 1929, clxxxiv, 261. CrossrefGoogle Scholar19. POLLOCKFLACKESSEXBOLLMAN HEHEJL: Phosphorus compounds in the perfused heart of the dog, Am. Jr. Physiol., 1934, cx, 197. Google Scholar20. HERRMANN G: (a) Serum calcium inorganic phosphorus and plasma proteins in cardiac edema and after diuresis, Proc. Soc. Exper. Biol. and Med., 1930, xxviii, 263; (b) Some observations on the relation of some blood chemical findings to cardiac function. Plasma proteins in congestive heart failure, Trans. Assoc. Am. Phys., 1931, xlvi, 360; (c) Some blood chemical findings in congestive heart failure before and after treatment, Southern Med. Jr., 1932, xxv, 934. CrossrefGoogle Scholar21. SCOTT LC: The determination of potassium in cardiac muscle and the presumable influence of the beta radiations on the rhythm, Jr. Clin. Invest., 1931, x, 745. DECHERD, G., and VISSCHER, M. B.: Energy metabolism of the failing heart, Jr. Exper. Med., 1934, lix, 195. CrossrefGoogle Scholar22. PEKELHARINGVAN HOOGENHUYZE CACJ: Die Bildung des Kreatins in Muskel bei Tonus and bei der Starre, Ztschr. f. physiol. Chem., 1910, lxiv, 262. CrossrefGoogle Scholar23. CONSTABEL F: Ueber den Kreatingehalt des menschlichen Herzmuskels bei verschiedenen Krankheitzuständen, Biochem. Ztschr., 1921, cxxii, 152. Google Scholar24. SEECOFLINEGARMYERS DPCRVC: The difference in creatine concentration of the left and right ventricular cardiac muscles, Arch. Int. Med., 1934, liii, 574. CrossrefGoogle Scholar25. COWAN DW: The creatine content of the myocardium of normal and abnormal human hearts, Am. Heart Jr., 1934, ix, 378. CrossrefGoogle Scholar26. HERRMANNDECHERD GG: Creatine mobilization in myocardial damage, Proc. Soc. Exper. Biol. and Med., 1934, xxxii, 477. CrossrefGoogle Scholar27. DECHERDHERRMANN GG: Creatine and glycogen content of normal and infarcted heart muscle of the dog, Proc. Soc. Exper. Biol. and Med., 1935, xxxii, 1304. Google Scholar28. CULLENWILKINSHARRISON GEWETR: The electrolyte content of hearts and other tissues from cases with various diseases, Jr. Biol. Chem., 1933, cii, 415. CrossrefGoogle Scholar29. SORG K: Ueber den Phosphatidgehalt verschiedener Muskelarten, Ztschr. f. physiol. Chem., 1929, clxxxii, 97. CrossrefGoogle Scholar30. WASSERMEYER H: Chemische Untersuchungen menschlicher Herzen, Deutsch. Arch. klin. Med., 1934, clxxvii, 573. Google Scholar31. WHITE AC: Ueber die Verteilung verschiedener Phosphorsäure-fraktionen auf die einzelen Herzabschnitte, Ztschr. f. physiol. Chem., 1929, clxxxiii, 184. CrossrefGoogle Scholar32. KUTCHERA-AICHENBERGER H: Ueber Herzschwäche, Wien. Arch. f. inn. Med., 1929, xviii, 209. Google Scholar33. WASSERMEYERROHRBACH HA: Ueber chemische und kolloid-chemische Prozesse im Herzmuskel bei der experimentelle Myokarditis, Schm. Archiv, 1932, b 375, 166. Google Scholar34. HERRMANNDECHERDERHARD GGP: Total creatine content of perfused rabbit hearts, Proc. Soc. Exper. Biol. and Med., 1934, xxxii, 547. CrossrefGoogle Scholar35. DECHERDHERRMANNDAVIS GGO: Further rabbit heart perfusion experiments with amino-acids, Proc. Soc. Exper. Biol. and Med., 1935, xxxii, 1302. CrossrefGoogle Scholar36. FISHERWILHELMI RBAE: The metabolism of creatine, Biochem. Jr., 1937, xxxi, 1136. CrossrefGoogle Scholar37. DAVENPORTFISHERWILHELMI HWRBAE: The metabolism of creatine, Biochem. Jr., 1938, xxxii, 262. CrossrefGoogle Scholar38. DECHERDHERRMANNERHARD GGP: The effect of myocardial destructive agents on the creatine content of the rabbit's heart, Proc. Soc. Exper. Biol. and Med., 1936, xxxiii, 519. CrossrefGoogle Scholar39. DECHERDSCHWABHERRMANNBROWN GEHGWO: Creatine content of hypertrophied rabbits' heart muscle, Proc. Soc. Exper. Biol. and Med., 1936, xxxiv, 864. CrossrefGoogle Scholar40. HERRMANN G: Creatine metabolism with especial reference to heart disease, Jr. Lab. and Clin. Med., 1935, xx, 890. DECHERD, G., and HERRMANN, G.: Effects of amino-acids on the creatine of rabbit heart muscle, Jr. Clin. Invest., 1935, xiv, 706. Google Scholar41. HERRMANN G: A possible biochemical basis of heart failure, Med. papers dedicated to Dr. Henry A. Christian, 1936, i, 17. HERRMANN, G., DECHERD, G., and SCHWAP., E. H.: Some biochemical factors in heart failure, Southern Med. Jr., 1936, xxix, 386. HERRMANN, G.: La Insufficiencia Cardiaca en Terminos Bioquimicos, Arch. Latinos Amer. de Cardiol. y Hematol., 1936, vi, 49. HERRMANN, G., DECHERD, G., and OLIVER, T.: (a) Creatine content of human hearts, Proc. Soc. Exper. Biol. and Med., 1936, xxxiv, 827; (b) The creatine content of the heart under various clinical conditions, Am. Heart Jr., 1936, xii, 689. HERRMANN, G., and DECHERD, G.: Some biochemical changes that accompany heart failure, Trans. Assoc. Am. Phys., 1936, li, 295. Google Scholar42. DECHERDBLUM GMJE: Phosphorus fractions in human heart muscle, Proc. Soc. Exper. Biol. and Med., 1938, xxxviii, 341. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Galveston, Texas*Read at the St. Louis meeting of the American College of Physicians, April 19, 1937.From the University of Texas, School of Medicine, Galveston, Texas.Aided by Grant No. 444 from the Committee on Scientific Research of the A. M. A. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySynergistic effect on cardiac energetics by targeting the creatine kinase system: in vivo application of high-resolution 31P-CMRS in the mouseTargeting mitochondrial dysfunction with elamipretideIntegrated landscape of cardiac metabolism in end-stage human nonischemic dilated cardiomyopathyHuman induced pluripotent stem cells for studying mitochondrial diseases in the heartMetabolic Reprogramming, Gut Dysbiosis, and Nutrition Intervention in Canine Heart DiseaseReview of Cardiac Metabolism and FDGCARDIOKIN1: Computational Assessment of Myocardial Metabolic Capability in Healthy Controls and Patients With Valve DiseasesModern view on chronic heart failure therapy: guidelines‑2020 key messages and adjuvant therapyHyperpolarized MR in cardiology: probing the heart of lifeMeasuring Myocardial Energetics with Cardiovascular Magnetic Resonance SpectroscopySS‐31 and NMN: Two paths to improve metabolism and function in aged heartsImpaired Myocardial Energetics Causes Mechanical Dysfunction in Decompensated Failing HeartsL-carnitine: to fuel or not to fuel the failing heart?Remodeling of substrate consumption in the murine sTAC model of heart failureMetabolic Profiling of the Diabetic Heart: Toward a Richer PictureCardiac Resynchronisation Therapy and Cellular Bioenergetics: Effects Beyond Chamber MechanicsThe role of mitochondrial cardiolipin in heart function and its implication in cardiac diseaseMyocardial MetabolismCardiac work is related to creatine kinase energy supply in human heart failure: a cardiovascular magnetic resonance spectroscopy studyMyocyte Metabolic Imaging with Hyperpolarised MRINovel Mitochondria-Targeting Peptide in Heart Failure TreatmentHuman Cardiac 31P-MR Spectroscopy at 3 Tesla Cannot Detect Failing Myocardial Energy Homeostasis during ExerciseCreatine kinase in ischemic and inflammatory disordersThe role of trimetazidine in cardiovascular disease: beyond an anti-anginal agentMetabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart FailureMetabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic ProfilingMetabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac functionMELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesisEnergetics in the Hypertrophied and Failing HeartModulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrateTrimetazidine and CardioprotectionLong Noncoding RNAs and MicroRNAs in Cardiovascular PathophysiologyMyocardial Metabolic Abnormalities and Cardiac DysfunctionMetabolic Flux as a Predictor of Heart Failure PrognosisFailing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidationResearch Advances in Heart FailureThe Failing Heart: Is It an Inefficient Engine or an Engine Out of Fuel?Allopurinol for Heart FailurePhosphotransfer Reactions in the Failing HeartEnhancing the metabolic substrate: PPAR-alpha agonists in heart failureNutritional Considerations in Adult Cardiothoracic Surgical PatientsEnergetic Basis for Heart FailureAnalysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart FailureMice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacityLoss of creatine in heart failure. A loss–win situation?Mitochondria: A mirror into cellular dysfunction in heart diseaseRole of diet and fuel overabundance in the development and progression of heart failureThe Failing Heart — An Engine Out of FuelThe structural basis of the contractile process in heart muscle under physiological and pathological conditionsStudy of Heart Mitochondria and Glycolytic Metabolism in Experimentally Induced Cardiac FailureDie allgemeine Pathologie des BlutkreislaufesMineralstoffwechsel und KreislaufMineralstoffwechsel und KreislaufHORMONAL FACTORS IN HEART DISEASE: THEIR ROLE IN MYOCARDIAL HYPERTROPHY, HYPOXIA AND ELECTROLYTE IMBALANCE*W. RAAB, M.D., F.A.C.P.Current Concepts in Digitalis TherapyStudies on whole blood and muscle creatine levels: Effect of systemic and local anoxia, of cardiac failure and compensation, and of alphatocopherol administrationThe Water and Electrolyte Content of the Human Heart in Congestive Heart Failure with and without DigitalizationDigitalis Poisoning and Its TreatmentWater and electrolyte content of cardiac and skeletal muscle in heart failure and myocardial infarctionEffect of Potassium and of Desoxycorticosterone Acetate in Acute Heart Injury in the RatNeurohormanal bedingte Herzkrankheiten (Pathogenese und Therapie)The influence of digitalis on the electrolyte and water balance of heart muscle 1 February 1939Volume 12, Issue 8Page: 1233-1244KeywordsCellsHeartHeart failureMyocardiumPathologists ePublished: 1 December 2008 Issue Published: 1 February 1939 PDF downloadLoading ...